Hubei Biocause Pharmaceutical Co., Ltd. (SHE: 000627)

Hubei Biocause Pharmaceutical Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 6, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Market Capitalization	14,328	14,031	15,612	16,353	24,061	34,782
Market Cap Growth	-41.67%	-10.13%	-4.53%	-32.03%	-30.82%	25.49%
Enterprise Value	32,733	26,861	31,650	24,591	16,247	38,559
PE Ratio	-	-21.85	50.91	31.94	39.06	18.48
PS Ratio	0.33	0.29	0.32	0.34	0.59	0.70
PB Ratio	0.70	0.42	0.45	0.44	0.70	1.01
P/FCF Ratio	-0.36	1.48	2.11	4.21	1.14	1.25
P/OCF Ratio	-0.37	1.47	2.07	3.92	1.12	1.22
EV/Sales Ratio	0.75	0.56	0.64	0.50	0.40	0.78
EV/EBITDA Ratio	-12.31	-15.10	160.83	63.25	13.97	10.94
EV/EBIT Ratio	-11.69	-14.29	299.00	81.79	14.78	11.20
EV/FCF Ratio	-1.38	2.84	4.28	6.33	0.77	1.38
Debt / Equity Ratio	0.49	0.76	0.81	0.42	0.22	0.18
Debt / EBITDA Ratio	-	-	110.89	36.05	6.41	1.75
Debt / FCF Ratio	-0.70	2.69	3.80	4.03	0.35	0.22
Quick Ratio	0.93	1.29	1.35	2.46	4.09	2.06
Current Ratio	2.00	2.03	2.20	3.79	6.35	2.98
Asset Turnover	0.15	0.16	0.18	0.19	0.18	0.26
Return on Equity (ROE)	-4.79%	-3.76%	1.42%	2.44%	3.24%	9.67%
Return on Assets (ROA)	-0.44%	-0.40%	0.02%	0.07%	0.31%	1.12%
Return on Capital (ROIC)	-2.31%	-1.93%	0.11%	0.39%	1.66%	6.04%
Earnings Yield	-5.70%	-4.65%	1.76%	2.88%	2.41%	5.11%
FCF Yield	-165.55%	67.47%	47.33%	23.76%	87.70%	80.16%
Dividend Yield	0.00%	-	3.60%	0.16%	0.21%	1.95%
Payout Ratio	0.00%	-	255.21%	81.01%	109.25%	13.63%
Buyback Yield / Dilution	-9.32%	-9.76%	2.97%	2.66%	1.97%	-0.41%
Total Shareholder Return	-9.32%	-9.76%	6.57%	2.82%	2.19%	1.54%

Source: S&P Capital IQ. Insurance template. Financial Sources.